Original Research
Published on 27 May 2022
Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.802548
- 2,311 views
- 8 citations
Type at least 3 characters
709 articles
Articles
Original Research
Published on 27 May 2022
Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.843991
- 3,259 views
- 7 citations
Original Research
Published on 26 May 2022
Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.866289
- 2,712 views
- 2 citations
Original Research
Published on 25 May 2022
Integrin-Linked Kinase Expression Characterizes the Immunosuppressive Tumor Microenvironment in Colorectal Cancer and Regulates PD-L1 Expression and Immune Cell Cytotoxicity
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.836005
- 3,790 views
- 3 citations
Systematic Review
Published on 25 May 2022
Fermented Dairy Food Intake and Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.812679
- 8,724 views
- 10 citations
Original Research
Published on 20 May 2022
The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.867658
- 2,871 views
Original Research
Published on 19 May 2022
Treatment Response, Survival Benefit and Safety Profile of PD-1 Inhibitor Plus Apatinib Versus Apatinib Monotherapy in Advanced Colorectal Cancer Patients
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.863392
- 1,730 views
- 2 citations
Original Research
Published on 19 May 2022
An Observational Study of Trifluridine/Tipiracil-Containing Regimen Versus Regorafenib-Containing Regimen in Patients With Metastatic Colorectal Cancer
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.867546
- 2,624 views
- 3 citations
Original Research
Published on 18 May 2022
Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.858712
- 2,239 views
- 2 citations
Original Research
Published on 17 May 2022
Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.870086
- 4,344 views
- 7 citations
Original Research
Published on 12 May 2022
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.870411
- 2,128 views
Original Research
Published on 12 May 2022
The Long Non-Coding RNA FAM222A-AS1 Negatively Modulates MiR-Let-7f to Promote Colorectal Cancer Progression
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.764621
- 2,191 views
- 5 citations
Original Research
Published on 12 May 2022
Seven DNA Methylation Biomarker Prediction Models for Monitoring the Malignant Progression From Advanced Adenoma to Colorectal Cancer
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.827811
- 2,604 views
- 2 citations
Correction
Published on 11 May 2022
Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.903586
- 1,202 views
- 1 citation
Editorial
Published on 10 May 2022
Editorial: Women in Colorectal Cancers
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.922131
- 1,346 views
Original Research
Published on 10 May 2022
Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study
in Gastrointestinal Cancers: Colorectal Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.850774
- 2,783 views
- 11 citations